Full description
The dataset will include demographic and relevant health data for 900 participants enrolled in the DysPOCUS trial. Participants will include individuals of all genders, aged 65 years and older, who are admitted to hospital with dyspnoea. Relevant health data will include vital signs, medical history, basic physical examination findings, outcomes from the modified Borg Dyspnoea Scale, the Lawton and Brody IADL survey, and the EQ-5D-5L. Participant involvement will be considered complete upon completion of the one-year follow-up. The trial dataset will only become available after the conclusion of the study, which is anticipated to occur in late 2030.Notes
HeSANDA 1.0.0Created: 2026-04-15
Updated: 2026-04-15
Issued: 2026-04-15
Collected:
Data time period: 2026 to , 2026 to ,
Subjects
Cardiology (incl. cardiovascular diseases) |
Clinical chemistry (incl. diagnostics) |
Emergency medicine |
User Contributed Tags
Login to tag this record with meaningful keywords to make it easier to discover
Identifiers
- DOI : 10.26188/32017941
